Website
News25/Ratings0
Latest news
25 items- SECSEC Form 10-Q filed by Chain Bridge I10-Q - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - Chain Bridge I (0001845149) (Filer)
- SECSEC Form NT 10-Q filed by Chain Bridge INT 10-Q - Chain Bridge I (0001845149) (Filer)
- 13D/GAmendment: SEC Form SC 13G/A filed by Chain Bridge ISC 13G/A - Chain Bridge I (0001845149) (Subject)
- 13D/GAmendment: SEC Form SC 13G/A filed by Chain Bridge ISC 13G/A - Chain Bridge I (0001845149) (Subject)
- 13D/GAmendment: SEC Form SC 13G/A filed by Chain Bridge ISC 13G/A - Chain Bridge I (0001845149) (Subject)
- 13D/GSEC Form SC 13G filed by Chain Bridge ISC 13G - Chain Bridge I (0001845149) (Subject)
- SECSEC Form DEFA14A filed by Chain Bridge IDEFA14A - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - Chain Bridge I (0001845149) (Filer)
- 13D/GAmendment: SEC Form SC 13G/A filed by Chain Bridge ISC 13G/A - Chain Bridge I (0001845149) (Subject)
- SECSEC Form DEFA14A filed by Chain Bridge IDEFA14A - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Other Events8-K - Chain Bridge I (0001845149) (Filer)
- SECSEC Form DEFA14A filed by Chain Bridge IDEFA14A - Chain Bridge I (0001845149) (Filer)
- SECSEC Form DEFA14A filed by Chain Bridge IDEFA14A - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Chain Bridge I (0001845149) (Filer)
- SECSEC Form DEF 14A filed by Chain Bridge IDEF 14A - Chain Bridge I (0001845149) (Filer)
- SECSEC Form PRER14A filed by Chain Bridge IPRER14A - Chain Bridge I (0001845149) (Filer)
- SECSEC Form PRE 14A filed by Chain Bridge IPRE 14A - Chain Bridge I (0001845149) (Filer)
- SECChain Bridge I filed SEC Form 8-K: Other Events8-K - Chain Bridge I (0001845149) (Filer)
- SECSEC Form 10-Q filed by Chain Bridge I10-Q - Chain Bridge I (0001845149) (Filer)
- SECSEC Form NT 10-Q filed by Chain Bridge INT 10-Q - Chain Bridge I (0001845149) (Filer)
- PRPhytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth PotentialNEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck. The updated presentation provides an in-depth look at the company's strategic vision, scientific advancements, and growth potential as it progresses towards the development of next-generation cannabinoid medicines. The global cannabis pharmaceuticals market size was estimated at USD 3.4 billion in 2023 and is anticipated to grow at a CAGR of 53.3% from 2024 to 2030. The investor deck is now available on
- SECSEC Form 425 filed by Chain Bridge I425 - Chain Bridge I (0001845149) (Subject)
- SECChain Bridge I filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Chain Bridge I (0001845149) (Filer)